Drug recall · January 17, 2018
Valsartan Tablets recall
Why: Failed Tablet/Capsule Specifications: confirmed customer complaint of thicker and heavier tablets in bottle.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Valsartan Tablets, USP, 160 mg, 90-count bottles, Rx Only, Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd, Xunqiao, Linhai, Zhejiang 317024, China; Distributed by: Solco Healthcare US, LLC, Cranbury, NJ 08512, USA; NDC 43547-369-09.
- Lots / codes
Lot #: 343B17025, Exp 03/31/19
- Quantity
- 21,987 bottles
- Company
- Prinston Pharmaceutical Inc, Cranbury, NJ
- Distribution
- Nationwide in the USA and Puerto Rico
- Initiated
- November 29, 2017 · Voluntary: Firm initiated
- Classified
- January 8, 2018
- Reported
- January 17, 2018
- Ended
- August 16, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Valsartan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.